Related Experiment Video
Updated: Aug 10, 2026
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
[Increase of the antigenicity of B16 melanoma cell membranes by microwave hyperthermia]
Abstract:
An injection of a suspension of B16 melanoma cell membranes, treated with micro-wave hyperthermia, increases the survival time of mice inoculated 26 days after with 10(7) (viability greater than 95%) of B16 melanoma. This delay (26 days) between these two injections corresponds to the moment where the synthesis of sera anticorps (IgG, IgA, IgM) is increased in "protected" mice. The earliest death of animals injected with untreated tumoral cell membranes and who received a suspension of B16 melanoma cells can be explained by an inhibition of humoral immunity system.
Insights
Injecting microwave-treated B16 melanoma cell membranes into mice significantly prolonged survival. This immunotherapy correlated with increased antibody production, suggesting a boosted humoral immunity system against melanoma.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Context:
- B16 melanoma is a highly aggressive mouse model for studying cancer.
- Microwave hyperthermia is an emerging physical therapy modality.
- Humoral immunity plays a critical role in anti-cancer responses.
Purpose:
- To investigate the immunomodulatory effects of microwave hyperthermia-treated B16 melanoma cell membranes.
- To determine the impact of this treatment on the survival of tumor-bearing mice.
- To explore the correlation between treatment, antibody synthesis, and anti-tumor immunity.
Summary:
- Mice injected with microwave hyperthermia-treated B16 melanoma cell membranes showed increased survival time after subsequent tumor cell inoculation.
- A 26-day delay between membrane injection and tumor cell inoculation coincided with elevated serum antibody (IgG, IgA, IgM) synthesis.
- Conversely, mice receiving untreated tumor cell membranes experienced earlier mortality, potentially due to suppressed humoral immunity.
Impact:
- This study highlights a potential novel immunotherapy approach for melanoma.
- Microwave hyperthermia-treated tumor cell membranes may serve as a vaccine to enhance anti-tumor immune responses.
- Findings suggest a mechanism involving the stimulation of humoral immunity for cancer protection.
More Related Videos
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025